Insiders affiliated with Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) sold approximately $192.6 million in company shares on August 20-21, 2026, according to regulatory filings.
Five entities linked to director Paul R. Vigano disposed of 15.7 million shares at a fixed price of $11.50 per share. J.H. Whitney VII, L.P. accounted for the largest block with 10.1 million shares valued at $116.3 million. PSA Healthcare Investment Holding LLC sold 3.2 million shares across two days, including 2.25 million shares under an over-allotment option, totaling $36.9 million. Remaining holdings of PSA Healthcare Investment Holding LLC were reported at 12.3 million shares after the transactions.
The secondary offerings were executed under firm commitment underwriting agreements. The sales followed Aveanna Healthcare’s second-quarter 2026 results, which showed revenue of $670.5 million, exceeding the $638.6 million consensus estimate and rising 13.7% year-over-year. Adjusted EBITDA also outperformed expectations by 16%.
Aveanna Healthcare’s stock closed at $13.17 on August 21, up 1.54%, and traded at $13.57 in after-hours, representing a nearly 19% increase from the $11.50 sale price. The shares were quoted near a 52-week high of $13.98. Over the past year, the stock has delivered an 83% return, with a 94% gain over the last six months.
Analysts raised price targets following the results. Raymond James increased its target to $15.00 from $13.00, maintaining a Strong Buy rating, while RBC Capital raised its target to $16.00 from $10.00. RBC cited expected growth from increased private duty nursing rates in California, slated for implementation in January 2027, as a supporting factor for the higher valuation.
